Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
INDGN Stock Analysis
Views
Red Flags
Positive
High and stable operating margin
Moderate revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
High ROE but declining trend
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
INDGN Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
INDGN Bulk, Block & Insider Trades
INDGN Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical S... Read More
Key personnel
Mr. Manish GuptaD
Executive Chairman of the Board, Chief Executive Officer
Mr. Suhas Prabhu
Chief Financial Officer
Dr. Sanjay Suresh Parikh, Ph.D.D
Executive Vice President, Executive Director
Mr. Anand Kiran Praf Nijegal
Executive Vice President - Global Operations
Ms. Srishti Ramesh Kaushik
Compliance Officer, Company Secretary
Mr. Viveksheel Ghai
Executive Vice President - Enterprise Commercial Solutions of Indegene, Inc.
Mr. Gaurav Kapoor
Executive Vice President of Indegene, Inc.
Mr. Sameer Lal
Senior Vice President - Business Development of Indegene, Inc.
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Indegene Ltd.?
The current share price of Indegene Ltd. is ₹ 477.63 as of 19 Jan 2026.
What is the PE ratio of Indegene Ltd.?
The Price-to-Earnings (PE) ratio of Indegene Ltd. is 25.72 as of the latest financial data.
What is the ROE and ROCE of Indegene Ltd.?
Indegene Ltd. has a Return on Equity (ROE) of 17.06% and a Return on Capital Employed (ROCE) of 18.01% as per the latest financial reports.
What is the market cap of Indegene Ltd.?
The market capitalization of Indegene Ltd. stands at ₹ 11,466.40 Cr.
What is the dividend yield of Indegene Ltd.?
The dividend yield of Indegene Ltd. is 0.42% based on the current market price.
What is the RSI of Indegene Ltd.?
The Relative Strength Index (RSI) of Indegene Ltd. is 19.87.
What is the FII and DII holding in Indegene Ltd.?
Foreign Institutional Investors (FII) hold 11.30% and Domestic Institutional Investors (DII) hold 3.08% of Indegene Ltd. shares.
What sector does Indegene Ltd. belong to?
Indegene Ltd. operates in the Healthcare sector.
What is the beta of Indegene Ltd. stock?
The beta of Indegene Ltd. stock is 0.82, indicating its volatility relative to the broader market.
